Tadayoshi Hirata

Healthcare innovation leveraged machine learning algorism, real-world data utilization, and ecosystem building

Yokohama, Kanagawa

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2024

  • Independent Healthcare Consultant

    2024

    Advisory services in the fields of medical science and healthcare business include: ・Assistance in research planning to generate evidence through the utilization of medical real-world data, machine learning algorithms, and medical science knowledge. ・Development and support for the social implementation of an AI-driven disease prognosis prediction system tailored for individual patients, suitable for integration into daily medical practices. ・Support for new business planning by establishing a healthcare ecosystem that links health promotion enterprises with data utilization businesses, aiming to achieve Digital Transformation (DX).

  • Director of the Board

    2023 - 2023

  • Director of the Board, Chief Operating Officer

    2021 - 2023

  • Director of the Board, Vice President of Business Development

    2021 - 2021

    Development and implication of medical digital twin applications using real-world data and machine learning algorithms that function on cloud-based regional EHR network systems for behavior change of multidisciplinary medical-care teams. Planning and implementation of investigation of previous research, precedent cases, interview survey with experts (healthcare and nursing care professionals) Consulting service for life science and healthcare IT service companies, and public-health service business

2021 - 2021

  • Independent Healthcare Consultant

    2021 - 2021

    Consulting service on business development for online medical-care platform, public-health support, and medical digital twin development companies

2016 - 2021

  • Associate Medical Director

    2018 - 2021

    Country Medical Lead for Infectious Disease and Gastroenterology, Medical Science, Medical Affairs Japan. Strategic lead for innovation of organizational capability of Medical Affairs and development of new business model with cross-divisional task force.

  • Associate Director, Business Development

    2016 - 2018

    Business Development of Next Generation Infectious Disease Vaccine Portfolio with open innovation networking at Product and Portfolio Strategy

2005 - 2016

  • Senior Director, Global Marketing Strategy

    2012 - 2016

    Global Head of Commercial Franchise - Infectious Diseases

  • Senior Director, Product and Portfolio Strategy

    2007 - 2012

    Global Therapeutic Area Head - Infecious Diseases

  • Director, Global Marketing

    2005 - 2006

    Group Leader - Infectious Diseaases and Gastroenterology

  • Director, Global Marketing

    2003 - 2005

    Global Brand Leader - Urology Portfolio LCM Establishment of Global Marketing Function

  • Associate Director, Product Planning

    1998 - 2002

    Project Officer and Business Analyst - Global Project Valuation at R&D Division Establishment of Global Project Valuation System/SOPs and Strategic Decision Making Under Uncertainty System

  • Product Manager, Japan Product Marketing

    1990 - 1998

    Product Manager - Oncology, Infecitous Diseases, and Gastroenterology

  • Sales Representative

    1984 - 1990